Interlaboratory variability of activated protein C resistance using the ETP‐based APC resistance assay

Abstract Background and objective Although the endogenous thrombin potential (ETP)‐based activated protein C (APC) resistance is recommended for the development of steroid contraceptive agents, one of the main limitations of this technique was its lack of standardization, which hampered study‐to‐stu...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Laure Morimont, Marie Didembourg, Hélène Haguet, Élise Modaffari, Maxence Tillier, Céline Bouvy, Aurélien Lebreton, Jean‐Michel Dogné, Jonathan Douxfils
Formato: article
Lenguaje:EN
Publicado: Wiley 2021
Materias:
Acceso en línea:https://doaj.org/article/6f6c0c8e38c345fcb29951359cce23f9
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:6f6c0c8e38c345fcb29951359cce23f9
record_format dspace
spelling oai:doaj.org-article:6f6c0c8e38c345fcb29951359cce23f92021-11-29T09:35:28ZInterlaboratory variability of activated protein C resistance using the ETP‐based APC resistance assay2475-037910.1002/rth2.12612https://doaj.org/article/6f6c0c8e38c345fcb29951359cce23f92021-10-01T00:00:00Zhttps://doi.org/10.1002/rth2.12612https://doaj.org/toc/2475-0379Abstract Background and objective Although the endogenous thrombin potential (ETP)‐based activated protein C (APC) resistance is recommended for the development of steroid contraceptive agents, one of the main limitations of this technique was its lack of standardization, which hampered study‐to‐study comparison. A validated methodology that meets all the regulatory requirements in terms of analytical performances has been developed recently. To ensure a wide implementation of this test, the assessment of the interlaboratory variability was needed. Method The assay was implemented in three testing laboratories. First, dose‐response curves were performed to locally define APC concentration leading to 90% of ETP inhibition on healthy donors. Intra‐ and inter‐run repeatability were assessed on a reference plasma and three quality controls. To investigate the variability in results among the different testing units, 60 donor samples were analyzed at each site. Results The APC concentration leading to 90% of ETP inhibition was defined at 1.21 µg/ml and 1.14 µg/ml in the two receiving units. Intra‐ and inter‐run repeatability showed standard deviation below 3%. Analyses of the 60 donor samples showed no statistically significant difference. The sensitivity of the test in the different laboratories was maintained and subgroup analyses still reported significant differences depending on hormonal status of donors. Conclusion This study is the first reporting the interlaboratory variability of the ETP‐based APC resistance assay. Data revealed excellent intra‐ and interlaboratory reproducibility. These results support the concept that this blood coagulation test provides an appropriate sensitivity irrespective of the laboratory in which analyses are performed.Laure MorimontMarie DidembourgHélène HaguetÉlise ModaffariMaxence TillierCéline BouvyAurélien LebretonJean‐Michel DognéJonathan DouxfilsWileyarticleactivated protein C resistanceblood coagulation testcontraceptive agentslaboratoriesreproducibility of resultsDiseases of the blood and blood-forming organsRC633-647.5ENResearch and Practice in Thrombosis and Haemostasis, Vol 5, Iss 7, Pp n/a-n/a (2021)
institution DOAJ
collection DOAJ
language EN
topic activated protein C resistance
blood coagulation test
contraceptive agents
laboratories
reproducibility of results
Diseases of the blood and blood-forming organs
RC633-647.5
spellingShingle activated protein C resistance
blood coagulation test
contraceptive agents
laboratories
reproducibility of results
Diseases of the blood and blood-forming organs
RC633-647.5
Laure Morimont
Marie Didembourg
Hélène Haguet
Élise Modaffari
Maxence Tillier
Céline Bouvy
Aurélien Lebreton
Jean‐Michel Dogné
Jonathan Douxfils
Interlaboratory variability of activated protein C resistance using the ETP‐based APC resistance assay
description Abstract Background and objective Although the endogenous thrombin potential (ETP)‐based activated protein C (APC) resistance is recommended for the development of steroid contraceptive agents, one of the main limitations of this technique was its lack of standardization, which hampered study‐to‐study comparison. A validated methodology that meets all the regulatory requirements in terms of analytical performances has been developed recently. To ensure a wide implementation of this test, the assessment of the interlaboratory variability was needed. Method The assay was implemented in three testing laboratories. First, dose‐response curves were performed to locally define APC concentration leading to 90% of ETP inhibition on healthy donors. Intra‐ and inter‐run repeatability were assessed on a reference plasma and three quality controls. To investigate the variability in results among the different testing units, 60 donor samples were analyzed at each site. Results The APC concentration leading to 90% of ETP inhibition was defined at 1.21 µg/ml and 1.14 µg/ml in the two receiving units. Intra‐ and inter‐run repeatability showed standard deviation below 3%. Analyses of the 60 donor samples showed no statistically significant difference. The sensitivity of the test in the different laboratories was maintained and subgroup analyses still reported significant differences depending on hormonal status of donors. Conclusion This study is the first reporting the interlaboratory variability of the ETP‐based APC resistance assay. Data revealed excellent intra‐ and interlaboratory reproducibility. These results support the concept that this blood coagulation test provides an appropriate sensitivity irrespective of the laboratory in which analyses are performed.
format article
author Laure Morimont
Marie Didembourg
Hélène Haguet
Élise Modaffari
Maxence Tillier
Céline Bouvy
Aurélien Lebreton
Jean‐Michel Dogné
Jonathan Douxfils
author_facet Laure Morimont
Marie Didembourg
Hélène Haguet
Élise Modaffari
Maxence Tillier
Céline Bouvy
Aurélien Lebreton
Jean‐Michel Dogné
Jonathan Douxfils
author_sort Laure Morimont
title Interlaboratory variability of activated protein C resistance using the ETP‐based APC resistance assay
title_short Interlaboratory variability of activated protein C resistance using the ETP‐based APC resistance assay
title_full Interlaboratory variability of activated protein C resistance using the ETP‐based APC resistance assay
title_fullStr Interlaboratory variability of activated protein C resistance using the ETP‐based APC resistance assay
title_full_unstemmed Interlaboratory variability of activated protein C resistance using the ETP‐based APC resistance assay
title_sort interlaboratory variability of activated protein c resistance using the etp‐based apc resistance assay
publisher Wiley
publishDate 2021
url https://doaj.org/article/6f6c0c8e38c345fcb29951359cce23f9
work_keys_str_mv AT lauremorimont interlaboratoryvariabilityofactivatedproteincresistanceusingtheetpbasedapcresistanceassay
AT mariedidembourg interlaboratoryvariabilityofactivatedproteincresistanceusingtheetpbasedapcresistanceassay
AT helenehaguet interlaboratoryvariabilityofactivatedproteincresistanceusingtheetpbasedapcresistanceassay
AT elisemodaffari interlaboratoryvariabilityofactivatedproteincresistanceusingtheetpbasedapcresistanceassay
AT maxencetillier interlaboratoryvariabilityofactivatedproteincresistanceusingtheetpbasedapcresistanceassay
AT celinebouvy interlaboratoryvariabilityofactivatedproteincresistanceusingtheetpbasedapcresistanceassay
AT aurelienlebreton interlaboratoryvariabilityofactivatedproteincresistanceusingtheetpbasedapcresistanceassay
AT jeanmicheldogne interlaboratoryvariabilityofactivatedproteincresistanceusingtheetpbasedapcresistanceassay
AT jonathandouxfils interlaboratoryvariabilityofactivatedproteincresistanceusingtheetpbasedapcresistanceassay
_version_ 1718407406698889216